Member Info for Ghia

TommyD - You have a nasty habit of dragging my name up?

I'm not sure what you believe me to be.

Perhaps you'd like to acknowledge that I correctly spotted the opportunity to realise a tax loss and gain shares in the process, did make me chuckle your comment that I had sold out at a low only for the real low to be hit in the following weeks.

Anyway yesterdays price action was very encouraging. Today we seem to have attracted some speculators, tomorrow will probably be the same.

It may be half tempting tomorrow to de-risk somewhat tomorrow.

Doc83 - It will be very interesting to see the action tomorrow if 13 holds it’s a very strong sign technically.

Could be a good buying opportunity in the morning.

Odd to see no one discussing Strive second agent?

Think it was an American president that popularised it calling people Negative Nellies over policies on Vietnam in the 60's

Very little happening spread is far too wide to encourage any business.

Seems everyone is poised for Thursday.

There will be a forward looking statement in the results the only positive sign I can see is that by reporting earlier than they technically need too they obviously have something they deem is relevant to put in that statement.

Otherwise they would be delaying to buy time to get some substance.

Aether - Can you please stop posting that link, posting in this manner is abusive. Trivialising and making fun of mental health is not acceptable in todays society there is no place for this behaviour.

Wpa5 - there is zero evidence to suggest TFG have continued buying. The volume has been non-existent in the channels they typically buy through.

It’s the same crap time and time again. Small glimmer of hope last week with some share price action on low volume.

Renewed cries of news inbound. Some real positivity around the board.

Then anti climax pull back and arguments with resident trolls.

If anyone was looking at buying into this share for the first time they might have been emboldened to do so over the weekend.

if they read the board this morning guarantee they will run a mile because you can’t just filter and ignore!

Doc no one cares stick to the science and the technicals and filter.

Why why why? You could have bought as many as you wanted for around 8p last week.

Size “ We won't be diluted if we get on STRIVE or another PT. This is key. Dilution is not envitable while these options remain.”

A funded trial like Strive does not negate the potential or requirement for dilution. It does however put us in a stronger position and the kick to the share price would make a market raise more feasible if required.

For what it’s worth I think it’s worth a punt on a quick return in the new tax year.

In and out on trial news.

Fruits - Everything you have described is still dilution it is dilution of the asset.

Until the model chosen to move forward is finalised you cannot put a number on this. You can assume it will be higher than todays price but putting a number is destined to disappoint people.

You can’t comment on a price target without knowing what has to be given away to get there.

We cannot get to a P3 without giving something in return the board will be trying to make that sacrifice as small as possible.

But throwing out price targets is mindless ramping. Given that we know we will need some form of dilution in the near future.

Mani - I know Hemo if you check out my sole post on Hemo you’ll see I could have saved a lot of people a lot of money on the pump and dump.

How much did you loose there?

Developing drugs takes decades.

The pandemic significantly reduced dev cycle times primarily due to the urgency to speed up decision making and the availability of trial participants.

Now we are in a post pandemic situation you’ll notice decision making takes longer, trials are taking longer the industry has shifted down a gear.

It was a huge missed opportunity by SNG not to get approval during the ripe period but let’s face it they had an uphill struggle all the way due to their size and resources available to them.

To suggest a drug in early stages of development is in anyway a threat to SNG is ludicrous come back in 5-8years and maybe.

By then SNG will be bang or bust anyway.

Fruits - I think you misunderstood the point I was making.

As far as the company have communicated with us *there is no concrete plan yet*

Once this concrete plan is communicated the money will come and the two may be hand in hand or closely following each other.

I’m not saying they don’t have a plan behind the scenes I’m just saying that we don’t know what it is yet.

And that the money isn’t here because it’s clearly not required right this second.

To be fair Tommy Mani is right your silence surrounding the full sprinter results is quite telling.

What do you actually make of them?

Mani with regards to funding my stance is if we had £100mil today as far as the companies communications are concerned we wouldn’t know what to do with it.

So until they figure out what to do cash is not the road block.

If they figure out what to do the cash will follow.

Mani - You clearly are concerned on funding.

Personally funding is not the main issue for me.

If they sort out an attractive route to commercialisation funding will sort itself.

This later point is taking time and may never materialise. Which is why I’m on the sidelines currently.

Companies fail P3 trials all the time and go on to have success.